AR098154A1 - RECOMBINANT GLICOPROTEINS AND THEIR USES - Google Patents
RECOMBINANT GLICOPROTEINS AND THEIR USESInfo
- Publication number
- AR098154A1 AR098154A1 ARP140103969A ARP140103969A AR098154A1 AR 098154 A1 AR098154 A1 AR 098154A1 AR P140103969 A ARP140103969 A AR P140103969A AR P140103969 A ARP140103969 A AR P140103969A AR 098154 A1 AR098154 A1 AR 098154A1
- Authority
- AR
- Argentina
- Prior art keywords
- recombinant
- galactosidase
- methods
- glicoproteins
- glycoproteins
- Prior art date
Links
Abstract
En la presente se proveen glicoproteínas recombinantes (por ejemplo, proteínas a-galactosidasa-A, humanas recombinantes) con un perfil de glicosilación alterado (por ejemplo, mejorado), así como composiciones farmacéuticas y kits que incluyen una o más de estas proteínas. También se proveen métodos para la generación de una célula de mamífero útil para la expresión recombinante de una glicoproteína (por ejemplo, a-galactosidasa-A humana recombinante), métodos para la producción de glicoproteínas recombinantes, y métodos para el tratamiento que incluyen administrar a un sujeto por lo menos una de las glicoproteínas recombinantes (por ejemplo, la proteína a-galactosidasa-A humana recombinante).Recombinant glycoproteins are provided herein (eg, recombinant human a-galactosidase-A proteins) with an altered (for example, enhanced) glycosylation profile, as well as pharmaceutical compositions and kits that include one or more of these proteins. Methods are also provided for the generation of a mammalian cell useful for the recombinant expression of a glycoprotein (for example, recombinant human a-galactosidase-A), methods for the production of recombinant glycoproteins, and methods for treatment that include administering to a subject at least one of the recombinant glycoproteins (eg, the recombinant human a-galactosidase-A protein).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361894879P | 2013-10-23 | 2013-10-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR098154A1 true AR098154A1 (en) | 2016-05-04 |
Family
ID=57867930
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP140103969A AR098154A1 (en) | 2013-10-23 | 2014-10-22 | RECOMBINANT GLICOPROTEINS AND THEIR USES |
Country Status (2)
Country | Link |
---|---|
AR (1) | AR098154A1 (en) |
MA (1) | MA39053B2 (en) |
-
2014
- 2014-10-22 MA MA39053A patent/MA39053B2/en unknown
- 2014-10-22 AR ARP140103969A patent/AR098154A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
MA39053B2 (en) | 2020-03-31 |
MA39053A1 (en) | 2018-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2017000507A2 (en) | Chimeric bcma antigen receptor | |
EA202090931A3 (en) | COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING WITH HYBRID PROTEINS | |
CO2018002196A2 (en) | Factor ix fusion proteins and methods to produce and use them | |
PE20190563A1 (en) | OPTIMIZED MINI-DISTROPHIN GENES AND EXPRESSION CASSETS AND THEIR USE | |
CO7121348A2 (en) | Interleukin-2 fusion proteins and uses thereof | |
BR112017024384A2 (en) | bacteria modified to reduce hyperphenylalaninemia | |
CL2015002567A1 (en) | Compounds and their uses to modulate hemoglobin | |
PE20150201A1 (en) | PROTEINS OF FIBROBLAST GROWTH FACTOR 21 | |
BR112014026740A8 (en) | antibody, composition, method of providing an antibody with enhanced adcc, and, use of an antibody | |
BR112015011933A2 (en) | synergistic bacterial compositions and methods of production and use thereof | |
BR112016015105A2 (en) | VAR2CSA-DRUG CONJUGATES | |
BR112015013525A2 (en) | a method for producing a fusion protein as well as a composition comprising a fusion protein | |
SV2017005416A (en) | VERY POWERFUL ACID ALFA-GLUCOSIDASE WITH POTENTIATED CARBON HYDRATES | |
BR112016027871A2 (en) | composition to improve memory, learning function and / or cognitive function | |
CL2018000671A1 (en) | Expression of recombinant proteins in trichoplusia pupae or | |
GT201200252A (en) | OPTIMIZED MONOCLONAL ANTIBODIES AGAINST THE INHIBITOR OF THE TISSULAR FACTOR ROUTE (TFPI) | |
BR112017017886A2 (en) | generating arterial endothelial cell populations | |
BR112017003905A2 (en) | extracellular matrix compositions | |
PE20151774A1 (en) | CONSTRUCTIONS OF MITOCHONDRIAL PROTEINS AND THEIR USES | |
UY34773A (en) | INDANOYLOXIDIHYDROBENZOFURANILACETIC ACIDS AS MODULATORS OF THE ACTIVITY OF GPR40, COMPOSITIONS CONTAINING THEM AND THEIR USES | |
DOP2016000079A (en) | RECOMBINANT GLICOPROTEINS AND ITS USES | |
AR095334A1 (en) | NUTRITIONAL COMPOSITIONS CONTAINING A PEPTIDE COMPONENT WITH STIMULATING PROPERTIES OF ADIPONECTINE AND METHOD TO PROMOTE A HEALTHY BODY WEIGHT | |
UY35438A (en) | PROCEDURE TO PREPARE INHIBITORS OF GLUCOSILCERAMIDE SINTASA. | |
BR112015028737A2 (en) | methods for hormone production and / or purification | |
BR112019000837A2 (en) | b cell mimetic cells |